Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-31

Clinical Trial Update: The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study) [NA]

View source ↗

Summary

Phase III trial of Sorbact antimicrobial dressing for holistic wound management in diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorbact Antimicrobial Dressing (Sorbact antimicrobial dressing)

Snippet

Sponsor: INRESA Pharma | Conditions: Foot Ulcer, Diabetic | NA | Status: COMPLETED